| Experience Co Limited (EXP) ORDINARY FULLY PAID |
Consumer Discretionary |
$91 |
FY25 Results Announcement
|
28 Aug 2025 6:38PM |
$0.130 |
$0.120 |
fallen by
7.69%
|
|
EXP - Price-sensitive ASX Announcement
Full Release
Key Points
- EXP reported on its operational and financial performance for FY25.
- The announcement covered revenue, EBITDA, and profit or loss figures for the period.
- Strategic initiatives and investments aimed at supporting long-term growth were detailed.
- The company provided updates on its adventure tourism portfolio and market recovery.
- Management discussed ongoing efforts to enhance customer experience and operational efficiency.
- Risks and market conditions impacting business performance were highlighted.
- Forward-looking statements about trading conditions and strategic priorities for FY25 were included.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clean TeQ Water Limited (CNQ) ORDINARY FULLY PAID |
Industrials |
$31 |
Appendix 4G and Corporate Governance Statement
|
28 Aug 2025 6:38PM |
$0.250 |
$0.360 |
risen by
44%
|
|
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$82 |
Appendix 4G & Corporate Governance Statement
|
28 Aug 2025 6:37PM |
$0.540 |
$0.930 |
risen by
72.22%
|
|
| Clean TeQ Water Limited (CNQ) ORDINARY FULLY PAID |
Industrials |
$31 |
Appendix 4E and Full Year Statutory Accounts
|
28 Aug 2025 6:36PM |
$0.250 |
$0.360 |
risen by
44%
|
|
CNQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Clean TeQ Water Limited reported a 121% increase in revenue for FY23, reaching $19.6 million.
- The net loss after tax was reduced to $1.2 million, down from $13.6 million in FY22.
- Growth was driven by project deliveries and technology sales expansion.
- The company maintained a strong cash position and continued investments in research and development.
- No dividends were paid or proposed for the period.
- The company is diversifying through both water treatment solutions and new battery materials.
- A robust pipeline of projects and strategic partnerships was noted as key to future growth.
- The company expects continued momentum and improved financial results in the coming year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Experience Co Limited (EXP) ORDINARY FULLY PAID |
Consumer Discretionary |
$91 |
FY25 Results Presentation
|
28 Aug 2025 6:35PM |
$0.130 |
$0.120 |
fallen by
7.69%
|
|
EXP - Price-sensitive ASX Announcement
Full Release
Key Points
- EXP achieved a return to profitability and improved financial performance in FY25.
- Strong growth in skydiving and adventure experiences, supported by a rebound in tourism.
- Focused on business transformation, including brand and digital platform improvements.
- Successfully controlled costs and generated robust cash flow.
- Strategic investments planned in high-margin products and targeted marketing.
- Enhanced customer experiences and product innovation remain top priorities.
- Outlined risks and opportunities, with a positive outlook for future performance.
- Strengthened market position as a leading adventure tourism operator in Australia and New Zealand.
- Board and management remain committed to driving sustainable growth and shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Liontown Limited (LTR) ORDINARY FULLY PAID |
Materials |
$4,351 |
Appendix 3Y - Jennifer Morris
|
28 Aug 2025 6:34PM |
$0.885 |
$1.480 |
risen by
67.23%
|
|
| AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$496 |
Change of Director's Interest Notice
|
28 Aug 2025 6:33PM |
$0.810 |
$1.000 |
risen by
23.46%
|
|
| Experience Co Limited (EXP) ORDINARY FULLY PAID |
Consumer Discretionary |
$91 |
Dividend/Distribution - EXP
|
28 Aug 2025 6:32PM |
$0.130 |
$0.120 |
fallen by
7.69%
|
|
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$58 |
Change in substantial holding
|
28 Aug 2025 6:28PM |
$0.780 |
$0.740 |
fallen by
5.13%
|
|
| HeraMED Limited (HMD) ORDINARY FULLY PAID |
Health Care |
$34 |
Appendix 4D and Half Year Report
|
28 Aug 2025 6:25PM |
$0.033 |
$0.033 |
fallen by
0%
|
|
HMD - Price-sensitive ASX Announcement
Full Release
Key Points
- HeraMED Limited released its Appendix 4D and Half Year Report for the period ended 31 December 2023.
- The company continues to focus on the global expansion of its digital maternity care platform, HeraCARE.
- Several pilot programs and commercial rollouts are ongoing with healthcare providers and insurers.
- Revenue for the half-year was $245,253, with a net loss of $1,697,564 after tax.
- The company made strategic investments in sales, marketing, and product development.
- No dividends were paid or declared for the period.
- The directors' report covers principal activities, review of operations, and significant changes during the year.
- Financial statements include the balance sheet, income statement, and cash flow statement for the half-year.
- The company holds sufficient cash reserves to support ongoing operations.
- Future outlook highlights continued focus on technology development and commercial partnerships in digital maternal healthcare.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$26 |
Cleansing Notice
|
28 Aug 2025 6:24PM |
$0.046 |
$0.029 |
fallen by
36.96%
|
|
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$63 |
Appendix 4G
|
28 Aug 2025 6:24PM |
$0.200 |
$0.265 |
risen by
32.50%
|
|
| Omnia Metals Group Limited (OM1) ORDINARY FULLY PAID |
Materials |
$5 |
Appendix 3Y x 3
|
28 Aug 2025 6:24PM |
$0.014 |
$0.018 |
risen by
28.57%
|
|
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$26 |
Application for quotation of securities - ARI
|
28 Aug 2025 6:23PM |
$0.046 |
$0.029 |
fallen by
36.96%
|
|
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$63 |
Corporate Governance Statement
|
28 Aug 2025 6:23PM |
$0.200 |
$0.265 |
risen by
32.50%
|
|
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$82 |
2025 Annual Report & Appendix 4E
|
28 Aug 2025 6:23PM |
$0.540 |
$0.930 |
risen by
72.22%
|
|
BB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- BlinkLab Limited has released its Annual Report & Appendix 4E for the year ended 31 December 2023.
- The company changed its financial year end from 30 June to 31 December as approved by shareholders at the 2023 AGM.
- The report details continued product development, pilot studies, and key milestones in advancing the commercialisation of their mobile-based neurobehavioral assessment platform.
- Significant achievements include the launch of the updated BlinkLab App, progression of clinical validation studies in Europe and the US, and partnerships with academic and commercial entities.
- Revenue for the period was modest, primarily from research and development tax incentives, with operating losses reflecting ongoing investment in product development and clinical trials.
- The company raised additional capital via a share placement and convertible note to support continued operations and growth.
- Emphasis was placed on expanding the intellectual property portfolio, securing patents, and enhancing regulatory compliance.
- Risks identified include competition, clinical trial outcomes, regulatory changes, and reliance on key personnel.
- The Board remains confident in the growth prospects and future commercialisation of BlinkLab’s technology.
- Governance, financial statements, auditor's report, and remuneration details are included, meeting compliance requirements for ASX-listed entities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$63 |
Appendix 4E & Annual Report
|
28 Aug 2025 6:23PM |
$0.200 |
$0.265 |
risen by
32.50%
|
|
CYP - Price-sensitive ASX Announcement
Full Release
Key Points
- Cynata Therapeutics Limited released its Appendix 4E and Annual Report for the year ended 30 June 2023.
- Significant progress was made in the development and clinical advancement of Cymerusâ„¢ stem cell technology.
- Positive clinical outcomes were achieved in trials, particularly with lead product candidates like CYP-001.
- Strategic partnerships and collaborations were expanded to support research and commercialization goals.
- The company reported a net loss after tax, consistent with expenses for research, development, and operations.
- Corporate governance, risk management, and remuneration frameworks were reviewed and outlined.
- Future plans focus on achieving further clinical trial milestones and progressing commercial opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$496 |
Notice under Section 708A of the Corporations Act 2001
|
28 Aug 2025 6:21PM |
$0.810 |
$1.000 |
risen by
23.46%
|
|
| Ainsworth Game Technology Limited (AGI) ORDINARY FULLY PAID |
Consumer Discretionary |
$338 |
Change in substantial holding
|
28 Aug 2025 6:21PM |
$1.000 |
$1.005 |
risen by
0.50%
|
|
| Brazilian Critical Minerals Limited (BCM) ORDINARY FULLY PAID |
Materials |
$40 |
Application for quotation of securities - BCM
|
28 Aug 2025 6:21PM |
$0.023 |
$0.021 |
fallen by
8.70%
|
|
| Steadfast Group Limited (SDF) ORDINARY FULLY PAID |
Financials |
$5,660 |
Chair succession and appointment of new Director
|
28 Aug 2025 6:21PM |
$6.140 |
$5.090 |
fallen by
17.10%
|
|
| Experience Co Limited (EXP) ORDINARY FULLY PAID |
Consumer Discretionary |
$91 |
FY25 Appendix 4E and Annual Report
|
28 Aug 2025 6:20PM |
$0.130 |
$0.120 |
fallen by
7.69%
|
|
EXP - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to $125.8 million for FY24.
- Underlying EBITDA reached $16.6 million.
- Statutory net profit after tax was $1.1 million, returning the company to profitability.
- Strong performance in both Skydiving and Adventure Experiences segments.
- Significant recovery in inbound international tourism and continued domestic demand.
- Strategic focus areas included digital transformation, product diversification, and sustainability initiatives.
- Ongoing cost management and operational efficiency programs implemented.
- Comprehensive corporate governance and risk management practices described.
- Remuneration report and details of Board and senior management provided.
- Positive outlook for FY25 with continued focus on growth and customer experience.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$18 |
Appendix 4G and Corporate Governance Statement
|
28 Aug 2025 6:20PM |
$0.150 |
$0.155 |
risen by
3.33%
|
|
| Steadfast Group Limited (SDF) ORDINARY FULLY PAID |
Financials |
$5,660 |
Steadfast Corporate Governance Statement 2025
|
28 Aug 2025 6:19PM |
$6.140 |
$5.090 |
fallen by
17.10%
|
|
| PLS Group Limited (PLS) ORDINARY FULLY PAID |
Materials |
$13,201 |
Application for quotation of securities - PLS
|
28 Aug 2025 6:19PM |
$2.300 |
$4.100 |
risen by
78.26%
|
|